About this trial
A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subjects with diabetes, inflammatory/autoimmune and transplant related renal conditions. Additionally, the repository will have the capacity to store biospecimens and electronic data in control subjects without established renal disease. This initiative will provide an opportunity to compare data from various disease states and controls with the objective of determining clinical and biological factors that predict disease progression, response to therapy and identify discriminating noninvasive clinical and biological features that predict renal biopsy findings.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Males or females
18 years of age and older
Willing and able to provide informed consent
Previously had a kidney biopsy and the tissue is not stored in this biorepository; or
Disqualifiers
None
Trial population
Subjects will be recruited from The Rogosin Institute, NewYork Presbyterian Hospital and affiliated institutions.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Change in disease progression
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
The Rogosin Institute
Lead sponsor
New York Presbyterian Hospital
Collaborator
Weill Medical College of Cornell University
Collaborator